PHARMA SECTOR

United States Microneedles for Trans / Intradermal Drug Delivery Market Report 2018: By Product, Application, Manufacturer, Sales and Segmentation

Press Release   •   Apr 12, 2018 09:04 EDT

The new research from Global QYResearch on United States Microneedles for Trans / Intradermal Drug Delivery Market Report for 2018 intends to offer target audience with the fresh outlook on market and fill in the knowledge gaps with the help of processed information and opinions from industry experts. The information in the research report is well-processed and a report is accumulated by industry professionals and seasoned experts in the field to ensure of the quality of research.

The research is backed by extensive and in-depth secondary research which involves reference to various statistical databases, national government documents, relevant patent and regulatory databases, news articles, press releases, company annual reports, webcasts, financial reports, and a number of internal and external proprietary databases. This estimated data is cross-checked with industry experts from various leading companies in the market. After the entire authentication process, these reports are shared with subject matter experts (SMEs) for adding further value and to gain their insightful opinion on the research. With such robust process of data extraction, verification, and finalization, we firmly endorse the quality of our research. With such extensive and in-depth research and comprehensive coverage of information, it is always a possibility of clients finding their desired information in the report with enclosure of key components and valuable statistics in all regards.

Download Sample Report Copy From Here: http://globalqyresearch.com/download-sample/445874

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Microneedles for Trans / Intradermal Drug Delivery in these regions, from 2013 to 2025 (forecast).

United States Microneedles for Trans / Intradermal Drug Delivery market competition by top manufacturers/players, with Microneedles for Trans / Intradermal Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Drugs
Vaccines
Proteins
Peptides
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Ask Query Here:Jay@globalqyresearch.com or Sales@globalqyresearch.com

Table of Contents

United States Microneedles for Trans / Intradermal Drug Delivery Market Report 2018

1 Microneedles for Trans / Intradermal Drug Delivery Overview
1.1 Product Overview and Scope of Microneedles for Trans / Intradermal Drug Delivery
1.2 Classification of Microneedles for Trans / Intradermal Drug Delivery by Product Category
1.2.1 United States Microneedles for Trans / Intradermal Drug Delivery Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Microneedles for Trans / Intradermal Drug Delivery Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Solid Microneedles
1.2.4 Hollow Microneedles
1.2.5 Dissolvable Microneedles
1.3 United States Microneedles for Trans / Intradermal Drug Delivery Market by Application/End Users
1.3.1 United States Microneedles for Trans / Intradermal Drug Delivery Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Drugs
1.3.3 Vaccines
1.3.4 Proteins
1.3.5 Peptides
1.3.6 Others
1.4 United States Microneedles for Trans / Intradermal Drug Delivery Market by Region
1.4.1 United States Microneedles for Trans / Intradermal Drug Delivery Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2013-2025)
1.4.3 Southwest Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2013-2025)
1.4.5 New England Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2013-2025)
1.4.6 The South Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2013-2025)
1.4.7 The Midwest Microneedles for Trans / Intradermal Drug Delivery Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Microneedles for Trans / Intradermal Drug Delivery (2013-2025)
1.5.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2013-2025)
1.5.2 United States Microneedles for Trans / Intradermal Drug Delivery Revenue and Growth Rate (2013-2025)

2 United States Microneedles for Trans / Intradermal Drug Delivery Market Competition by Players/Suppliers
2.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Microneedles for Trans / Intradermal Drug Delivery Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Microneedles for Trans / Intradermal Drug Delivery Average Price by Players/Suppliers (2013-2018)
2.4 United States Microneedles for Trans / Intradermal Drug Delivery Market Competitive Situation and Trends
2.4.1 United States Microneedles for Trans / Intradermal Drug Delivery Market Concentration Rate
2.4.2 United States Microneedles for Trans / Intradermal Drug Delivery Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Microneedles for Trans / Intradermal Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type

3 United States Microneedles for Trans / Intradermal Drug Delivery Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Region (2013-2018)
3.2 United States Microneedles for Trans / Intradermal Drug Delivery Revenue and Market Share by Region (2013-2018)
3.3 United States Microneedles for Trans / Intradermal Drug Delivery Price by Region (2013-2018)

4 United States Microneedles for Trans / Intradermal Drug Delivery Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Microneedles for Trans / Intradermal Drug Delivery Revenue and Market Share by Type (2013-2018)
4.3 United States Microneedles for Trans / Intradermal Drug Delivery Price by Type (2013-2018)
4.4 United States Microneedles for Trans / Intradermal Drug Delivery Sales Growth Rate by Type (2013-2018)

5 United States Microneedles for Trans / Intradermal Drug Delivery Sales (Volume) by Application (2013-2018)
5.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Application (2013-2018)
5.2 United States Microneedles for Trans / Intradermal Drug Delivery Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Microneedles for Trans / Intradermal Drug Delivery Players/Suppliers Profiles and Sales Data
6.1 Becton Dickinson
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Nanopass Technologies
6.2.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Radius Health
6.3.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Radius Health Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Clearside Biomedical
6.4.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Dr. Prausnitz Group
6.5.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Dr. Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Zosano Pharma
6.6.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Corium International
6.7.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Corium International Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Circassia
6.8.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Circassia Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Valeritas, Inc.
6.9.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Valeritas, Inc. Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 BD Medical
6.10.2 Microneedles for Trans / Intradermal Drug Delivery Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 BD Medical Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview

7 Microneedles for Trans / Intradermal Drug Delivery Manufacturing Cost Analysis
7.1 Microneedles for Trans / Intradermal Drug Delivery Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Microneedles for Trans / Intradermal Drug Delivery

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Microneedles for Trans / Intradermal Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Microneedles for Trans / Intradermal Drug Delivery Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Microneedles for Trans / Intradermal Drug Delivery Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Microneedles for Trans / Intradermal Drug Delivery Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Microneedles for Trans / Intradermal Drug Delivery Sales Volume Forecast by Type (2018-2025)
11.3 United States Microneedles for Trans / Intradermal Drug Delivery Sales Volume Forecast by Application (2018-2025)
11.4 United States Microneedles for Trans / Intradermal Drug Delivery Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaime

The report is readily available and can be dispatched within 4hr after payment confirmation.

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/445874

About Us:

Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best pssible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 3286 1546